Should I buy Envista Holdings (NVST) stock or is it too late?

Envista Holdings · Health Care · price $23

See the full Envista Holdings (NVST) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 64% of its targets hit on this sector (124 calls tested). It aims for $27 (+19 %), call made on September 19, 2026, maturing on September 19, 2027 (25 d ago).

The 2 reliable analysts $29.50+30 %

The 7 other firms $29+28 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $29.50 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Envista Holdings

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	40 %	+60.5 %	5	$32 +41%
Stifel	50 %	+5.5 %	6	$31 +37%
Morgan Stanley	0 %	-19.5 %	9	$21 -7%

In short — Should you invest in Envista Holdings? Is it too late, still worth it? Analysts are split (44% buy, median target $29, i.e. +28%), and the most reliable on NVST targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $29, i.e. +28% from the current price ($23).
The most reliable firm on NVST, Evercore ISI Group (100% hit rate, 4 scored calls), targets $33 (call made on May 7, 2026, maturing on May 7, 2027) (+46%) in its most recent call, and $30 (call made on April 8, 2026, maturing on April 8, 2027) (+32%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 5 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on NVST

Median target $29 (+28%) · 9 ratings · Hold consensus

Strong Buy00%

Buy444%

Hold556%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Envista Holdings now?

We won't decide for you. The facts: 44% of analysts rate it a buy, median target $29 (+28%), and Evercore ISI Group (most reliable on NVST, 100%) targets $33. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Envista Holdings?

Not according to analysts: the median target ($29) is still +28% above the current price ($23) (most reliable on NVST: Evercore ISI Group, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Envista Holdings still worth investing in?

It depends on the gap between the price ($23) and its estimated value: analysts target $29 on median (+28%), with 44% buys (most reliable on NVST: Evercore ISI Group, 100%). Cross-check with their real reliability on NVST and the cautions above. Information, not advice.

What's the main risk in buying NVST?

The consensus is not unanimous: of 9 ratings, 5 are neutral.

→ Go deeper: the full Envista Holdings profile (consensus, analyst reliability, price target, performance).